PF597 HIGH DOSE MELPHALAN (200MG/M2) AND AUTOLOGOUS TRANSPLANTATION IN NEWLY-DIAGNOSED MULTIPLE MYELOMA UP TO THE AGE OF 70 YEARS: A SUBGROUP ANALYSIS FROM THE PHASE III GMMG-MM5 TRIALE.K. Mai, K. Miah,M. Merz,J. Dürig,C. Scheid,K.C. Weisel,C. Kunz,U. Bertsch,M. Munder,H.‐W. Lindemann,D. Hose,A. Jauch,A. Seckinger, S. Luntz,S. Sauer,S. Fuhrmann,P. Brossart,A. Elmaagacli,M. Goerner,H. Bernhard, M. Hoffmann,M.S. Raab,I.W. Blau,M. Hänel,A. Benner,H.J. Salwender,H. GoldschmidtHemaSphere（2019）引用 0|浏览6AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
